| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |